Berlin-based Aignostics, developers of digital pathology solutions, has completed an oversubscribed €14m ($14m) series A financing round.
The round was led by Wellington Partners – who were involved in Quanta Dialysis’ $245m series D round – and was joined by Boehringer Ingelheim Venture Fund (BIVF), VC Fonds...